Intervention Review

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

  1. Beti W Evans1,*,
  2. Wendy K Clark2,
  3. David J Moore3,
  4. Peter J Whorwell4

Editorial Group: Cochrane IBD Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 30 JUL 2007

DOI: 10.1002/14651858.CD003960.pub3


How to Cite

Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003960. DOI: 10.1002/14651858.CD003960.pub3.

Author Information

  1. 1

    University of Hertfordshire, School of Pharmacy, Hatfield, UK

  2. 2

    Keele University, Medicines Management, Newcastle-under-Lyme, Staffordshire, UK

  3. 3

    University of Birmingham, Aggressive Research Intelligence Facility, University of Birmingham, West Midlands, UK

  4. 4

    Wythenshawe Hospital, Medical Academic Department, Manchester, UK

*Beti W Evans, School of Pharmacy, University of Hertfordshire, College Lane Campus, Hatfield, AL10 9AB, UK. b.w.evans@herts.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

  1. Current Version

    Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

    Beti W Evans, Wendy K Clark, David J Moore and Peter J Whorwell

    Version of Record online: 17 OCT 2007 | DOI: 10.1002/14651858.CD003960.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Tegaserod for the treatment of irritable bowel syndrome

    BW Evans, WK Clark, DJ Moore and PJ Whorwell

    Version of Record online: 26 JAN 2004 | DOI: 10.1002/14651858.CD003960.pub2

  2. Version 1

    Tegaserod for the treatment of irritable bowel syndrome

    BW Evans, WK Clark, DJ Moore, Whorwell and PJ

    Version of Record online: 6 NOV 2002 | DOI: 10.1002/14651858.CD003960